Crossmark

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.03.003

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Serino, M.

Freitas, C. http://orcid.org/0000-0002-7162-414X
Martins, M. http://orcid.org/0000-0003-2850-2558
Ferreira, P. http://orcid.org/0000-0003-3986-2997
Cardoso, C. http://orcid.org/0000-0002-5483-9317
Veiga, F.

Santos, V.

Araújo, D.

Novais-Bastos, H.

Magalhães, A.

Queiroga, H.

Fernandes, G.

Hespanhol, V.
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2022-03-23
More Information

This article is maintained by: Elsevier

Article Title: Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Journal Title: Pulmonology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2022.03.003

Content Type: article

Copyright: © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.